# Endoscopic Assessment and Prediction of Microbiome-modifying Interventions

> **NCT03218579** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 45 (estimated)

## Conditions studied

- Gut Microbiome
- Antibiotic Side Effect

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic treatment
- **BIOLOGICAL:** Bacteriotherapy

## Key facts

- **NCT ID:** NCT03218579
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02-01
- **Primary completion:** 2019-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2017-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03218579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03218579, "Endoscopic Assessment and Prediction of Microbiome-modifying Interventions". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03218579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*